Statements Of Consolidated Cash Flows (USD $) In Millions, unless otherwise specified	3 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Statement of Cash Flows [Abstract]
NET EARNINGS	$ 295.2	$ 328.6
Adjustments to reconcile net earnings to cash flows provided by operating activities:
Depreciation and amortization	68.3	64.0
Deferred income taxes	9.2	17.2
Stock-based compensation expense	38.8	23.3
Excess tax benefit related to exercise of stock options and restricted stock	(44.2)	(34.8)
Net pension expense	10.1	7.4
Net realized gain from the sales of marketable securities	(0.8)	(3.5)
Net amortization of premiums and accretion of discounts on available-for-sale securities	25.3	22.8
Other	(6.1)	6.3
Changes in operating assets and liabilities, net of effects from acquisitions and divestitures of businesses:
Increase in accounts receivable	29.9	20.1
Increase in other assets	(224.5)	(283.7)
Decrease in accounts payable	(9.2)	(8.3)
Increase in accrued expenses and other liabilities	(14.2)	(35.5)
Proceeds from the sale of notes receivable	207.2	0
Operating activities of discontinued operations	(6.8)	(42.6)
Net cash flows provided by operating activities	378.2	81.3
Cash Flows from Investing Activities:
Purchases of corporate and client funds marketable securities	(894.2)	(369.1)
Proceeds from the sales and maturities of corporate and client funds marketable securities	595.2	571.6
Net increase in restricted cash and cash equivalents held to satisfy client funds obligations	1.5	2,390.5
Capital expenditures	(36.5)	(34.4)
Additions to intangibles	(44.0)	(30.9)
Acquisitions of businesses, net of cash acquired	(8.1)	0
Proceeds from the sale of property, plant, and equipment and other assets	23.6	0
Dividend received from Disposal Entity	825.0	0
Cash retained by Disposal	(180.0)	0
Investing activities of discontinued operations	(15.4)	(23.6)
Net cash flows provided by investing activities	267.1	2,504.1
Cash Flows from Financing Activities:
Net increase in client funds obligations	47.3	(5,295.0)
Payments of debt	(0.6)	(0.6)
Repurchases of common stock	(61.2)	(303.0)
Proceeds from stock purchase plan and exercises of stock options	16.5	54.9
Excess tax benefit related to exercise of stock options and restricted stock	44.2	34.8
Dividends paid	(229.8)	(210.6)
Net (purchases of)/proceeds from reverse repurchase agreements	0	98.7
Net proceeds from issuance of commercial paper	(236.0)	2,477.0
Financing activities of discontinued operations	1.6	6.3
Net cash flows provided by financing activities	(418.0)	(3,137.5)
Effect of exchange rate changes on cash and cash equivalents	(35.2)	2.0
Net change in cash and cash equivalents	192.1	(550.1)
Cash and cash equivalents, beginning of period	1,983.6	1,699.1
Cash and cash equivalents, end of period	2,175.7	1,149.0
Less cash and cash equivalents of discontinued operations, end of period	0	309.0
Cash and cash equivalents of continuing operations, end of period	$ 2,175.7	$ 840.0